Acta Scientific Pharmaceutical Sciences (ASPS)(ISSN: 2581-5423)

Short Communication Volume 5 Issue 1

Wide Spread Use of Monoclonal Antibody would have Prevented Massive Death Rate from Covid-19 Infection

Tapan K Chaudhuri* and Richard Hoffler

Hampton, VA and San Antonio, TX, USA

*Corresponding Author: Tapan K Chaudhuri, Hampton, VA, USA. E-mail: tkchaudhuri44@gmail.com

Received: January 27, 2021; Published: January 30, 2020

×

  If the use of Monoclonal Antibody (MoAb) to COVID-19 saved the life of the President of the United States and several other people in his circle, then why are we not using the same therapy for everybody else. If we aggressively motivate to start the use of MoAb to COVID-19 infection, we can prevent a lot of deaths. It’s a magic bullet, it’s a cure.

×

Citation

Citation: Tapan K Chaudhuri and Richard Hoffler. “Wide Spread Use of Monoclonal Antibody would have Prevented Massive Death Rate from Covid-19 Infection". Acta Scientific Pharmaceutical Sciences 5.2 (2021): 67.




Metrics

Acceptance rate32%
Acceptance to publication20-30 days

Indexed In




News and Events


  • Reviewer Certificate
    Certificate will be issues to the valued reviewer who worked on the Articles Peer Review process.
  • Publication Certificate
    Authors will be provided with the Publication Certificate after their successful publication
  • Last Date for submission
    Authors are requested to submit their manuscripts before September 30, 2025

Contact US